Reporter nanoparticle that monitors its anticancer efficacy in real time
- 29 March 2016
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (15) , 201603455-13
Abstract
Significance: The ability to identify responders and nonresponders very early during chemotherapy by direct visualization of the activity of the anticancer treatment and to switch, if necessary, to a regimen that is effective can have a significant effect on the outcome as well as quality of life. Current approaches to quantify response rely on imaging techniques that fail to detect very early responses. In the case of immunotherapy, the early anatomical readout is often discordant with the biological response. This study describes a self-reporting nanomedicine that not only delivers chemotherapy or immunotherapy to the tumor but also reports back on its efficacy in real time, thereby identifying responders and nonresponders early on.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (1R01CA135242)
- DOD | Congressionally Directed Medical Research Programs (BC132168)
- DOD | Congressionally Directed Medical Research Programs (W81XWH-09-1-0700)
- American Lung Association (LCD-259932-N)
- American Cancer Society (122854-PF-12-226-01-CDD)
This publication has 75 references indexed in Scilit:
- Intra-tumour heterogeneity: a looking glass for cancer?Nature Reviews Cancer, 2012
- Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectivesNanoscale, 2011
- Target-Cancer-Cell-Specific Activatable Fluorescence Imaging Probes: Rational Design and in Vivo ApplicationsAccounts of Chemical Research, 2010
- Design and fabrication of magnetic nanoparticles for targeted drug delivery and imagingAdvanced Drug Delivery Reviews, 2010
- A dual-emissive-materials design concept enables tumour hypoxia imagingNature Materials, 2009
- Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probesNature Medicine, 2009
- An Improved Cell-Penetrating, Caspase-Activatable, Near-Infrared Fluorescent Peptide for Apoptosis ImagingBioconjugate Chemistry, 2009
- Activatable Molecular Systems Using Homologous Near-Infrared Fluorescent Probes for Monitoring Enzyme Activitiesin Vitro,in Cellulo, andin VivoMolecular Pharmaceutics, 2009
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Exploiting nanotechnology to target cancerBritish Journal of Cancer, 2007